Featured Research

from universities, journals, and other organizations

Walking to work cuts risk of diabetes and high blood pressure

Date:
August 6, 2013
Source:
Imperial College London
Summary:
People who walk to work are around 40 per cent less likely to have diabetes as those who drive, according to a new study.

People who walk to work are around 40 per cent less likely to have diabetes as those who drive, according to a new study.

Researchers at Imperial College London and University College London examined how various health indicators related to how people get to work, using data from a survey of 20,000 people across the UK.

They found that cycling, walking, and using public transport were all associated with lower risk of being overweight than driving or taking a taxi. People who walk to work were also 17% less likely than people who drive to have high blood pressure. Cyclists were around half as likely to have diabetes as drivers.

The findings are published in the American Journal of Preventive Medicine.

High blood pressure, diabetes, and being overweight are all major risk factors for heart and circulatory disease, the UK's biggest killer.

The researchers said people could reduce their risks of serious health problems such as heart attacks by avoiding using a car.

"This study highlights that building physical activity into the daily routine by walking, cycling or using public transport to get to work is good for personal health ," said Anthony Laverty, from the School of Public Health at Imperial College London.

Nineteen per cent of working age adults who use private transport -- such as cars, motorbikes or taxis -- to get to work were obese, compared to 15 per cent of those who walked and 13 per cent of those who cycled to work.

The study found wide variations in the modes of transport used in different parts of the UK. Public transport was used most in London, at 52 per cent, compared with just five per cent in Northern Ireland.

"The variations between regions suggest that infrastructure and investment in public transport, walking and cycling can play a large role in encouraging healthy lives, and that encouraging people out of the car can be good for them as well as the environment," said Laverty.


Story Source:

The above story is based on materials provided by Imperial College London. Note: Materials may be edited for content and length.


Journal Reference:

  1. Christopher Millett, Sutapa Agrawal, Ruth Sullivan, Mario Vaz, Anura Kurpad, A. V. Bharathi, Dorairaj Prabhakaran, Kolli Srinath Reddy, Sanjay Kinra, George Davey Smith, Shah Ebrahim. Associations between Active Travel to Work and Overweight, Hypertension, and Diabetes in India: A Cross-Sectional Study. PLoS Medicine, 2013; 10 (6): e1001459 DOI: 10.1371/journal.pmed.1%u200B001459

Cite This Page:

Imperial College London. "Walking to work cuts risk of diabetes and high blood pressure." ScienceDaily. ScienceDaily, 6 August 2013. <www.sciencedaily.com/releases/2013/08/130806091549.htm>.
Imperial College London. (2013, August 6). Walking to work cuts risk of diabetes and high blood pressure. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2013/08/130806091549.htm
Imperial College London. "Walking to work cuts risk of diabetes and high blood pressure." ScienceDaily. www.sciencedaily.com/releases/2013/08/130806091549.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins